| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 14 |
serial mean |
395.0 |
beats/min |
7.0 |
26.19 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65468 |
151 |
| BN.GH-(D6Mit12-D6Rat15)/Mcwi |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127.0 days-143.0 days |
16 |
serial mean |
381.3 |
beats/min |
8.0 |
32.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
microrenathane catheter; recover for 1 week after surgery |
|
11538 |
101 |
| SHRSP/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
125.0 days-127.0 days |
10 |
serial mean |
442.0 |
beats/min |
9.17 |
29.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13291 |
334 |
| SHR.BN-(D2Rat226-D2Rat294)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 22 |
continuous mean |
350.0 |
beats/min |
4.0 |
18.76 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65421 |
306 |
| SHR.BN-(D2Rat226-D2Rat294)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 22 |
continuous mean |
340.0 |
beats/min |
5.0 |
23.45 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65422 |
306 |
| SHR.BN-(D4Rat33-D4Rat54)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 23 |
continuous mean |
363.0 |
beats/min |
5.0 |
23.98 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65423 |
306 |
| SHR.BN-(D16Rat87-D16Mgh1)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 22 |
continuous mean |
361.0 |
beats/min |
6.0 |
28.14 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65426 |
306 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
329.0 |
beats/min |
13.0 |
31.84 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
84561 |
1120 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
326.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
84560 |
1120 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) and cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
424.0 |
beats/min |
7.0 |
17.15 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104672 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (3 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
370.0 |
beats/min |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104706 |
2988 |
| SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
423.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104751 |
2988 |
| SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
392.0 |
beats/min |
7.0 |
17.15 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104799 |
2988 |
| SR/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-57.0 days |
|
|
451.0 |
beats/min |
12.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138375 |
2801 |
| SHR |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 23 |
continuous mean |
365.0 |
beats/min |
3.0 |
14.39 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65353 |
306 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 12 |
serial mean |
427.0 |
beats/min |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
65469 |
151 |
| WKY/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112.0 days
| 12 |
serial mean |
408.0 |
beats/min |
8.95 |
31.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13284 |
334 |
| WKY/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
112.0 days
| 12 |
serial mean |
343.0 |
beats/min |
10.1 |
35.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13279 |
334 |
| SHRSP/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
112.0 days
| 12 |
serial mean |
394.0 |
beats/min |
7.22 |
25.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13288 |
334 |
| WKY/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
125.0 days-127.0 days |
11 |
serial mean |
349.0 |
beats/min |
12.06 |
40.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13286 |
334 |
| SHR.BN-(D16Rat87-D16Mgh1)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 23 |
continuous mean |
354.0 |
beats/min |
8.0 |
38.37 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65425 |
306 |
| WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
317.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
69086 |
1120 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
94.0 days
| 16 |
serial mean |
370.1 |
beats/min |
6.3 |
25.2 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
|
|
69525 |
151 |
| WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
306.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
84549 |
1120 |
| WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
320.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
84550 |
1120 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
370.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104668 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
357.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104670 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) and Capsazepine (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
370.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104671 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
360.0 |
beats/min |
21.0 |
51.44 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104695 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (1 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
367.0 |
beats/min |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104705 |
2988 |
| SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
430.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104775 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
398.0 |
beats/min |
16.0 |
39.19 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104774 |
2988 |
| SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then V1-Cal (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
446.0 |
beats/min |
13.0 |
31.84 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104776 |
2988 |
| HsdCpb:WU |
heart rate |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175.0 days
| 6 |
|
336.0 |
beats/min |
35.0 |
85.73 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108839 |
3130 |
| HsdCpb:WU |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175.0 days
| 10 |
|
331.0 |
beats/min |
14.0 |
44.27 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108838 |
3130 |
| MWF/Hsd |
heart rate |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175.0 days
| 10 |
|
416.0 |
beats/min |
38.0 |
120.17 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108841 |
3130 |
| SR/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-56.0 days |
|
|
454.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138355 |
2801 |
| SS/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-56.0 days |
|
|
467.0 |
beats/min |
18.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138356 |
2801 |
| SS/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-57.0 days |
|
|
499.0 |
beats/min |
15.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138377 |
2801 |
| GH/Omr |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127.0 days-143.0 days |
21 |
serial mean |
365.0 |
beats/min |
5.02 |
23.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
microrenathane catheter; recover for 1 week after surgery |
|
11524 |
101 |
| BN.GH-(D2Rat22-D2Mgh11)/Mcwi |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127.0 days-143.0 days |
19 |
serial mean |
349.8 |
beats/min |
7.34 |
32.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
microrenathane catheter; recover for 1 week after surgery |
|
11531 |
101 |
| BN/Elh |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127.0 days-143.0 days |
21 |
serial mean |
362.0 |
beats/min |
6.98 |
32.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
microrenathane catheter; recover for 1 week after surgery |
|
11552 |
101 |
| SHRSP/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112.0 days
| 11 |
serial mean |
416.0 |
beats/min |
9.65 |
32.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13289 |
334 |
| SHRSP/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
125.0 days-127.0 days |
12 |
serial mean |
433.0 |
beats/min |
4.33 |
15.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13290 |
334 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89.0 days-92.0 days |
20 |
serial mean |
437.0 |
beats/min |
6.0 |
26.83 |
vascular indwelling catheter method |
left femoral artery |
|
|
|
|
13310 |
151 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89.0 days-92.0 days |
20 |
serial mean |
367.0 |
beats/min |
5.0 |
22.36 |
vascular indwelling catheter method |
left femoral artery |
|
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
13309 |
151 |
| SHR.BN-(D2Rat114-D2Rat123)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 22 |
continuous mean |
362.0 |
beats/min |
5.0 |
23.45 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65417 |
306 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
321.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
69087 |
1120 |
| SHRSP/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
287.0 |
beats/min |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
69088 |
1120 |
| SS/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.14 M sodium (4.4-4.6 ul/hr) (for 14 days) and aldosterone (22.5 ng/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-57.0 days |
|
|
465.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138451 |
2801 |
| SR/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-56.0 days |
|
|
437.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138354 |
2801 |
| SS/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-56.0 days |
|
|
513.0 |
beats/min |
19.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138357 |
2801 |
| SS/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-57.0 days |
|
|
453.0 |
beats/min |
13.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138376 |
2801 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 20 |
serial mean |
369.9 |
beats/min |
5.1 |
22.81 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
|
|
69519 |
151 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89.0 days-91.0 days |
15 |
serial mean |
442.0 |
beats/min |
6.5 |
25.17 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
69450 |
151 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
345.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104666 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
377.0 |
beats/min |
13.0 |
31.84 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104667 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
385.0 |
beats/min |
15.0 |
36.74 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104696 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
433.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104701 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.1 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
362.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104703 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
371.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104747 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
413.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104750 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
385.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104771 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then V1-Cal (1 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
400.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104797 |
2988 |
| HsdCpb:WU |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
84.0 days
| 5 |
|
359.0 |
beats/min |
18.0 |
40.25 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108778 |
3130 |
| SHR.BN-(D4Rat33-D4Rat54)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 22 |
continuous mean |
340.0 |
beats/min |
6.0 |
28.14 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65424 |
306 |
| Crl:WI |
heart rate |
control condition |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
heart pumping trait |
male |
days
| 13 |
|
363.0 |
beats/min |
8.0 |
28.84 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
70420 |
1418 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 11 |
serial mean |
446.8 |
beats/min |
9.7 |
32.17 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
|
|
69520 |
151 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
353.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104669 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then Capsazepine (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
5 |
|
366.0 |
beats/min |
7.0 |
15.65 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104673 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
352.0 |
beats/min |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104693 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) and cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
443.0 |
beats/min |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104699 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then Capsazepine (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
5 |
|
356.0 |
beats/min |
14.0 |
31.3 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104700 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
368.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104704 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
350.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104702 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then Capsazepine (3 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
5 |
|
356.0 |
beats/min |
7.0 |
15.65 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104709 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) and cyclosporine A (2.5 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
409.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104708 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then V1-Cal (1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
428.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104749 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
370.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104748 |
2988 |
| SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then V1-Cal (1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
439.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104752 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
377.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104772 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then cyclosporine A (2.5 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
389.0 |
beats/min |
15.0 |
36.74 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104798 |
2988 |
| SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then V1-Cal (1 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
391.0 |
beats/min |
15.0 |
36.74 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104800 |
2988 |
| MWF/Hsd |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
84.0 days
| 5 |
|
364.0 |
beats/min |
14.0 |
31.3 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108779 |
3130 |
| MWF/Hsd |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175.0 days
| 9 |
|
364.0 |
beats/min |
28.0 |
84.0 |
vascular indwelling catheter method |
heart |
0.0 |
|
|
|
108840 |
3130 |
| SS/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-57.0 days |
|
|
490.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138450 |
2801 |
| SHR |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 24 |
continuous mean |
380.0 |
beats/min |
8.0 |
39.19 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65346 |
306 |
| BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127.0 days-143.0 days |
21 |
serial mean |
361.7 |
beats/min |
7.2 |
33.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
microrenathane catheter; recover for 1 week after surgery |
|
11545 |
101 |
| WKY/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
125.0 days-127.0 days |
10 |
serial mean |
380.0 |
beats/min |
11.07 |
35.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
3 sets of readings per day for two days |
13287 |
334 |
| SHR.BN-(D2Rat114-D2Rat123)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 23 |
continuous mean |
361.0 |
beats/min |
7.0 |
33.57 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
65416 |
306 |
| Crl:WI |
heart rate |
controlled NG-nitroarginine methyl ester content drinking water (20 mg/kg/d) (between 0 and 672 hours) |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
heart pumping trait |
male |
days
| 15 |
|
378.0 |
beats/min |
7.0 |
27.11 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
70419 |
1418 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
92.0 days
| 21 |
serial mean |
425.4 |
beats/min |
10.5 |
48.12 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
|
|
69514 |
151 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
92.0 days
| 21 |
serial mean |
386.5 |
beats/min |
9.6 |
43.99 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
|
|
69513 |
151 |
| SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
94.0 days
| 10 |
serial mean |
411.7 |
beats/min |
10.6 |
33.52 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
|
|
69526 |
151 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89.0 days-91.0 days |
18 |
serial mean |
386.0 |
beats/min |
4.1 |
17.39 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
69449 |
151 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
410.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104674 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
373.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104694 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
420.0 |
beats/min |
9.0 |
22.05 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104697 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) and Capsazepine (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
385.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104698 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) and Capsazepine (3 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
383.0 |
beats/min |
16.0 |
39.19 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104707 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then cyclosporine A (2.5 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
399.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104710 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then V1-Cal (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
432.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104773 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
378.0 |
beats/min |
16.0 |
39.19 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104795 |
2988 |
| SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) then myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56.0 days-70.0 days |
6 |
|
363.0 |
beats/min |
9.0 |
22.05 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
104796 |
2988 |
| SR/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49.0 days-57.0 days |
|
|
435.0 |
beats/min |
19.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
|
|
138374 |
2801 |